BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 38665916)

  • 1. O-GlcNAc transferase regulates collagen deposition and fibrosis resolution in idiopathic pulmonary fibrosis.
    Vang S; Helton ES; Guo Y; Burpee B; Rose E; Easter M; Bollenbecker S; Hirsch MJ; Matthews EL; Jones LI; Howze PH; Rajasekaran V; Denson R; Cochran P; Attah IK; Olson H; Clair G; Melkani G; Krick S; Barnes JW
    Front Immunol; 2024; 15():1387197. PubMed ID: 38665916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-GlcNAc regulates anti-fibrotic genes in lung fibroblasts through EZH2.
    Wu QP; Vang S; Zhou JQ; Krick S; Barnes JW; Sanders YY
    J Cell Mol Med; 2024 Apr; 28(7):e18191. PubMed ID: 38494860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-GlcNAc Transferase Regulates Angiogenesis in Idiopathic Pulmonary Arterial Hypertension.
    Barnes JW; Tian L; Krick S; Helton ES; Denson RS; Comhair SAA; Dweik RA
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis.
    Liang H; Xu C; Pan Z; Zhang Y; Xu Z; Chen Y; Li T; Li X; Liu Y; Huangfu L; Lu Y; Zhang Z; Yang B; Gitau S; Lu Y; Shan H; Du Z
    Mol Ther; 2014 Jun; 22(6):1122-1133. PubMed ID: 24594795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysyl Hydroxylase Inhibition by Minoxidil Blocks Collagen Deposition and Prevents Pulmonary Fibrosis via TGF-β₁/Smad3 Signaling Pathway.
    Shao S; Zhang X; Duan L; Fang H; Rao S; Liu W; Guo B; Zhang X
    Med Sci Monit; 2018 Nov; 24():8592-8601. PubMed ID: 30481795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling.
    Epstein Shochet G; Brook E; Bardenstein-Wald B; Shitrit D
    Respir Res; 2020 Feb; 21(1):56. PubMed ID: 32070329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype.
    Epstein Shochet G; Wollin L; Shitrit D
    Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis.
    Vuga LJ; Milosevic J; Pandit K; Ben-Yehudah A; Chu Y; Richards T; Sciurba J; Myerburg M; Zhang Y; Parwani AV; Gibson KF; Kaminski N
    PLoS One; 2013; 8(12):e83120. PubMed ID: 24376648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirtuin 7 is decreased in pulmonary fibrosis and regulates the fibrotic phenotype of lung fibroblasts.
    Wyman AE; Noor Z; Fishelevich R; Lockatell V; Shah NG; Todd NW; Atamas SP
    Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L945-L958. PubMed ID: 28385812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SEMA3B inhibits TGFβ-induced extracellular matrix protein production and its reduced levels are associated with a decline in lung function in IPF.
    Yombo DJK; Ghandikota S; Vemulapalli CP; Singh P; Jegga AG; Hardie WD; Madala SK
    Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1659-C1668. PubMed ID: 38646784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual inhibition of α
    Decaris ML; Schaub JR; Chen C; Cha J; Lee GG; Rexhepaj M; Ho SS; Rao V; Marlow MM; Kotak P; Budi EH; Hooi L; Wu J; Fridlib M; Martin SP; Huang S; Chen M; Muñoz M; Hom TF; Wolters PJ; Desai TJ; Rock F; Leftheris K; Morgans DJ; Lepist EI; Andre P; Lefebvre EA; Turner SM
    Respir Res; 2021 Oct; 22(1):265. PubMed ID: 34666752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis.
    Barnes JW; Duncan D; Helton S; Hutcheson S; Kurundkar D; Logsdon NJ; Locy M; Garth J; Denson R; Farver C; Vo HT; King G; Kentrup D; Faul C; Kulkarni T; De Andrade JA; Yu Z; Matalon S; Thannickal VJ; Krick S
    Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L141-L154. PubMed ID: 31042083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GRK2 promotes activation of lung fibroblast cells and contributes to pathogenesis of pulmonary fibrosis through increasing Smad3 expression.
    Li Y; Sun Y; Wu N; Ma H
    Am J Physiol Cell Physiol; 2022 Jan; 322(1):C63-C72. PubMed ID: 34852209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-L1 mediates lung fibroblast to myofibroblast transition through Smad3 and β-catenin signaling pathways.
    Guo X; Sunil C; Adeyanju O; Parker A; Huang S; Ikebe M; Tucker TA; Idell S; Qian G
    Sci Rep; 2022 Feb; 12(1):3053. PubMed ID: 35197539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of microRNA-9 reduces inflammatory response and fibroblast proliferation in mice with idiopathic pulmonary fibrosis through the ANO1-mediated TGF-β-Smad3 pathway.
    Dai WJ; Qiu J; Sun J; Ma CL; Huang N; Jiang Y; Zeng J; Ren BC; Li WC; Li YH
    J Cell Physiol; 2019 Mar; 234(3):2552-2565. PubMed ID: 30144053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Digoxin alleviates pulmonary fibrosis by regulating phosphatidylinositol-3-kinase/Akt signaling through inhibiting the activation of fibroblast: an in vivo and in vitro experiment].
    Jia L; Yang M; Tian X; Zhao P; Mei X; Bai Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov; 34(11):1161-1166. PubMed ID: 36567559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Mechanisms for the Antifibrotic Action of Nintedanib.
    Rangarajan S; Kurundkar A; Kurundkar D; Bernard K; Sanders YY; Ding Q; Antony VB; Zhang J; Zmijewski J; Thannickal VJ
    Am J Respir Cell Mol Biol; 2016 Jan; 54(1):51-9. PubMed ID: 26072676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of Shenlong Jianji treatment of idiopathic pulmonary fibrosis inhibits fibroblast-to-myofibroblast transformation via the TGF-β1/smads signaling pathway.
    Pan J; Li Y; Wu X; Pan X; Liu C; Zhang H; Wang L; Jiang X; Wang J; Zang N; Pang L; Lv X
    J Ethnopharmacol; 2024 Mar; 322():117507. PubMed ID: 38122910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vardenafil Activity in Lung Fibrosis and In Vitro Synergy with Nintedanib.
    Bourne MH; Kottom TJ; Hebrink DM; Choudhury M; Leof EB; Limper AH
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.